Skip to main content Accessibility help
×
Home

Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010

  • F. J. Charlson (a1) (a2) (a3), A. J. Baxter (a1) (a2) (a3), T. Dua (a4), L. Degenhardt (a3) (a5) (a6), H. A. Whiteford (a1) (a2) (a3) and T. Vos (a3)...

Abstract

Aims.

Mortality-associated burden of disease estimates from the Global Burden of Disease 2010 (GBD 2010) may erroneously lead to the interpretation that premature death in people with mental, neurological and substance use disorders (MNSDs) is inconsequential when evidence shows that people with MNSDs experience a significant reduction in life expectancy. We explore differences between cause-specific and excess mortality of MNSDs estimated by GBD 2010.

Methods.

GBD 2010 cause-specific death estimates were produced using the International Classification of Diseases death-coding system. Excess mortality (all-cause) was estimated using natural history models. Additional mortality attributed to MNSDs as underlying causes but not captured through GBD 2010 methodology is quantified in the comparative risk assessments.

Results.

In GBD 2010, MNSDs were estimated to be directly responsible for 840 000 deaths compared with more than 13 million excess deaths using natural history models.

Conclusions.

Numbers of excess deaths and attributable deaths clearly demonstrate the high degree of mortality associated with these disorders. There is substantial evidence pointing to potential causal pathways for this premature mortality with evidence-based interventions available to address this mortality. The life expectancy gap between persons with MNSDs and the general population is high and should be a focus for health systems reform.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

* Address for correspondence: F. Charlson, Queensland Centre for Mental Health Research, Locked bag 500, Sumner Park BC, Qld 4074, Australia. (Email: Fiona_charlson@qcmhr.uq.edu.au)

References

Hide All
Ahmadi, N, Hajsadeghi, F, Mirshkarlo, HB, Budoff, M, Yehuda, R, Ebrahimi, R (2011). Post-traumatic stress disorder, coronary atherosclerosis, and mortality. American Journal of Cardiology 108, 2933.
Bailey, S, Thorpe, L, Smith, G (2013). Whole-person Care: from Rhetoric to Reality. Achieving Parity between Mental and Physical Health. Royal College of Psychiatrists: UK.
Baker, A, Lee, N, Jenner, L (2005). Models of intervention and care for psychostimulant users. Australian Government Department of Health and Ageing , 6382.
Baxter, AJ, Charlson, FJ, Somerville, AJ, Whiteford, HA (2011 a). Mental disorders as risk factors: assessing the evidence for the global burden of disease study. BMC Medicine 9, 134.
Baxter, AJ, Page, A, Whiteford, HA (2011 b). Factors influencing risk of premature mortality in community cases of depression: a meta-analytic review. Epidemiology Research International 2011, 12.
Baxter, AJ, Vos, T, Scott, KM, Norman, RE, Flaxman, AD, Blore, J, Whiteford, HA (2014). The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010. International Journal of Methods in Psychiatric Research, doi: 10.1002/mpr.1444.
Bilder, D, Botts, E, Smith, K, Pimentel, R, Farley, M, Viskochil, J, Mcmahon, W, Block, H, Ritvo, E, Ritvo, R-A, Coon, H (2013). Excess mortality and causes of death in autism spectrum disorders: a follow up of the 1980s Utah/UCLA Autism Epidemiologic Study. Journal of Autism and Developmental Disorders 43, 11961204.
Bittles, AH, Petterson, BA, Sullivan, SG, Hussain, R, Glasson, EJ, Montgomery, PD (2002). The influence of intellectual disability on life expectancy. Journal of Gerontology 57A, M470M472.
Brugal, MT, Domingo-Salvany, A, Puig, R, Barrio, G, Garcia De Olalla, P, De La Fuente, L (2005). Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 100, 981989.
Byass, P (2010). The imperfect world of global health estimates. PLoS Medicine 7, e1001006.
Caplehorn, JRM, Drummer, OH (1999). Mortality associated with New South Wales methadone programs in 1994: lives lost and saved. Medical Journal of Australia 170, 104109.
Carpio, A, Bharucha, NE, Jallon, P, Beghi, E, Campostrini, R, Zorzetto, S, Mounkoro, PP (2005). Mortality of epilepsy in developing countries. Epilepsia 46, 2832.
Centre for Mental Health (2010). The Economic and Social Costs of Mental Health Problems in 2009/10 [Online]. London: Centre for Mental Health. Retrieved November 2013 from: http://www.centreformentalhealth.org.uk/pdfs/Economic_and_social_costs_2010.pdf.
Chang, C-K, Hayes, RD, Perera, G, Broadbent, MTM, Fernandes, AC, Lee, WE, Hotopf, M, Stewart, R (2011). Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS ONE 6, e19590. doi:10.1371/journal.pone.0019590.
Charlson, FJ, Stapelberg, N, Baxter, AJ, Whiteford, H (2011). Should global burden of disease estimates include depression as a risk factor for coronary heart disease? BMC Medicine 9, 47.
Charlson, FJ, Moran, AE, Freedman, G, Norman, RE, Stapelberg, NJC, Baxter, AJ, Vos, T, Whiteford, HA (2013). The contribution of major depression to the global burden of ischaemic heart disease: a comparative risk assessment. BMC Medicine 11, 250.
Chesney, E, Goodwin, GE, Fazel, S (2014). Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry 13, 153160.
Crump, C, Winkleby, MA, Sundquist, K, Sundquist, J (2013). Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. American Journal of Psychiatry 170, 324333.
Cullen, BA, Mcginty, EE, Zhang, Y, Dosreis, SC, Steinwachs, DM, Guallar, E, Daumit, GL (2013). Guideline-concordant antipsychotic use and mortality in schizophrenia. Schizophrenia Bulletin 39, 11591168.
Darke, S, Degenhardt, L, Mattick, RP (eds) (2006). Mortality Amongst Illicit Drug Users. Cambridge University Press: Cambridge.
Davoli, M, Forastiere, F, Abeni, DD, Rapiti, E, Perucci, CA (1994). Longitudinal and cross-sectional mortality studies in injecting drug users. Journal of Epidemiology and Community Health 48, 101102.
Degenhardt, L, Hall, W (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 379, 5570.
Degenhardt, L, Hall, WD, Lynskey, M, Mcgrath, J, Mclaren, J, Calabria, B, Whiteford, H, Vos, T (2009 a). Should burden of disease estimates include cannabis use as a risk factor for psychosis? PLOS Medicine 6, e1000133.
Degenhardt, L, Randall, D, Hall, W, Law, M, Butler, T, Burns, L (2009 b). Mortality among clients of a state-wide opioid pharmacotherapy programme over 20 years: risk factors and lives saved. Drug and Alcohol Dependence 105, 915.
Degenhardt, L, Mathers, B, Vickerman, P, Rhodes, T, Latkin, C, Hickman, M (2010). Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 376, 285301.
Degenhardt, L, Bucello, C, Mathers, B, Briegleb, C, Ali, H, Hickman, M, Mclaren, J (2011). Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 106, 3251.
Degenhardt, L, Whiteford, HA, Ferrari, AJ, Baxter, AJ, Charlson, FJ, Hall, WD, Freedman, G, Burstein, R, Johns, N, Engell, RE, Flaxman, A, Murray, CJL, Vos, T (2013). Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 382, 15641574.
De Hert, M, Detraux, J, Van Winkel, R, Yu, W, Correll, CU (2012). Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nature Reviews Endocrinology 8, 114126.
Dieterich, M, Irving, CB, Park, B, Marshall, M (2010). Intensive Case Management for Severe Mental Illness. Cochrane Database of Systematic Reviews [Online]. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007906.pub2/abstract.
Diop, AG, Hesdorffer, DC, Logroscino, G, Hauser, WA (2005). Epilepsy and mortality in Africa: a review of the literature. Epilepsia 46, 3335.
Druss, BG, Von Esenwein, SA, Compton, MT, Rask, KJ, Zhao, L, Parker, RM (2010). A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. American Journal of Psychiatry 167, 151159.
Erskine, HE, Ferrari, AJ, Nelson, P, Polanczyk, GV, Flaxman, AD, Vos, T, Whiteford, HA, Scott, JG (2013). Research Review: epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010. Journal of Child Psychology and Psychiatry 54, 12631274.
Ferrari, AJ, Norman, RE, Freedman, G, Baxter, AJ, Pirkis, JE, Harris, MG, Page, A, Carnahan, E, Degenhardt, L, Vos, T, Whiteford, HA (2014). The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. PLoS ONE 9, e91936.
Galea, S, Worthington, N, Piper, TM, Nandi, VV, Curtis, M, Rosenthal, DM (2006). Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addictive Behaviors 31, 907912.
Gibson, A, Degenhardt, L, Mattick, RP, Ali, R, White, J, O'Brien, S (2008). Exposure to opioid maintenance treatment reduces long-term mortality. Addiction 103, 462468.
Guehne, U, Riedel-Heller, S, Angermeyer, MC (2005). Mortality in dementia: a systematic review. Neuroepidemiology 25, 153162.
Hall, W, Kimber, J (2005). Being realistic about benefits of supervised injecting facilities. Lancet 366, 271272.
Haukka, J, Tiihonen, J, Härkänen, T, Lönnqvist, J (2008). Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia. Pharmacoepidemiology and Drug Safety 17, 686696.
Hitiris, N, Mohanraj, R, Norrie, J, Brodie, MJ (2007). Mortality in epilepsy. Epilepsy and Behavior 10, 363376.
Hoyer, EH, Mortensen, PB, Olesen, AV (2000). Mortality and causes of death ina total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. British Journal of Psychiatry 176, 7682.
Institute of Health Metrics and Evaluation (2013). GBD Compare [Online]. Seattle: University of Washington. http://viz.healthmetricsandevaluation.org/gbd-compare/.
Institute for Health Metrics and Evaluation (2014). What Countries are in Each Region? [Online]. Seattle: University of Washington. Retrieved 29 May 2014 from http://www.healthdata.org/gbd/faq#Whatcountriesareineachregion?
Jerome, L, Segal, A, Habinski, L (2006). What we know about ADHD and driving risk: a literature review, meta-analysis and critique. Journal of the Canadian Academy of Child and Adolescent Psychiatry 15, 105125.
Jette, N, Trevathan, E (2014). Saving lives by treating epilepsy in developing countries. Neurology 82, 552553.
Jilek, AL, Rwiza, HT (1992). Prognosis of epilepsy in a rural African community: a 30-year follow-up of 164 patients in a outpatient clinic in rural Tanzania. Epilepsia 33, 645650.
Joukamaa, M, Heliovaara, M, Knekt, P, Aromaa, A, Raitasalo, R, Lehtinen, V (2006). Schizophrenia, neuroleptic medication and mortality. British Journal of Psychiatry 188, 122127.
Kamgno, J, Pion, SDS, Boussinesq, M (2003). Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon. Epilepsia 44, 956963.
Kilbourne, AM, Rofey, DL, Mccarthy, JF, Post, EP, Welsh, D, Blow, FC (2007). Nutrition and exercise behavior among patients with bipolar disorder1. Bipolar Disorders 9, 443452.
Knapp, PW, Soares, B, Farrell, M, Silva De Lima, M (2007). Psychosocial Interventions for Cocaine and Psychostimulant Amphetamines Related Disorders. Cochrane Database of Systematic Reviews [Online], 2007. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003023.pub2/full
Laursen, TM (2011). Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophrenia Research 131, 101104.
Lawrence, D, Mitrou, F, Zubrick, S (2009). Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health 9, 285.
Lawrence, D, Hancock, KJ, Kisely, S (2013). The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. British Medical Journal 2013, f2539.
Lawrinson, P, Ali, R, Buavirat, A, Chiamwongpaet, S, Dvoryak, S, Habrat, B, Jie, S, Mardiati, R, Mokri, A, Moskalewicz, J, Newcombe, D, Poznyak, V, Subata, E, Uchtenhagen, A, Utami, DS, Vial, R, Zhao, C (2008). Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction 103, 14841492.
Lee, L.-C., Harrington, RA, Chang, JJ, Connors, SL (2008). Increased risk of injury in children with developmental disabilities. Research in Developmental Disabilities 29, 247255.
Li, Z, Page, A, Martin, G, Taylor, R (2011). Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review. Social Science and Medicine 72, 608616.
Lim, SS, Vos, T, Flaxman, AD, Danaei, G, Shibuya, K, Adair-Rohani, H, Amann, M, Anderson, HR, Andrews, KG, Aryee, M, Atkinson, C, Bacchus, LJ, Bahalim, AN, Balakrishnan, K, Balmes, J, Barker-Collo, S, Baxter, A, Bell, ML, Blore, JD, Blyth, F, Bonner, C, Borges, G, Bourne, R, Boussinesq, M, Brauer, M, Brooks, P, Bruce, NG, Brunekreef, B, Bryan-Hancock, C, Bucello, C, Buchbinder, R, Bull, F, Burnett, RT, Byers, TE, Calabria, B, Carapetis, J, Carnahan, E, Chafe, Z, Charlson, F, Chen, H, Chen, JS, Cheng, AT-A, Child, JC, Cohen, A, Colson, KE, Cowie, BC, Darby, S, Darling, S, Davis, A, Degenhardt, L, Dentener, F, Des Jarlais, DC, Devries, K, Dherani, M, Ding, EL, Dorsey, ER, Driscoll, T, Edmond, K, Ali, SE, Engell, RE, Erwin, PJ, Fahimi, S, Falder, G, Farzadfar, F, Ferrari, A, Finucane, MM, Flaxman, S, Fowkes, FGR, Freedman, G, Freeman, MK, Gakidou, E, Ghosh, S, Giovannucci, E, Gmel, G, Graham, K, Grainger, R, Grant, B, Gunnell, D, Gutierrez, HR, Hall, W, Hoek, HW, Hogan, A, Hosgood III, HD, Hoy, D, Hu, H, Hubbell, BJ, Hutchings, SJ, Ibeanusi, SE, Jacklyn, GL, Jasrasaria, R, Jonas, JB, Kan, H, Kanis, JA, Kassebaum, N, Kawakami, N, Khang, Y-H, Khatibzadeh, S, Khoo, J-P, Kok, C, Laden, F, Lalloo, R, Lan, Q, Lathlean, T, Leasher, JL, Leigh, J, Li, Y, Lin, JK, Lipshultz, SE, London, S, Lozano, R, Lu, Y, Mak, J, Malekzadeh, R, Mallinger, L, Marcenes, W, March, L, Marks, R, Martin, R, McGale, P, McGrath, J, Mehta, S, Mensah, GA, Merriman, TR, Micha, R, Michaud, C, Mishra, V, Hanafiah, KM, Mokdad, AA, Morawska, L, Mozaffarian, D, Murphy, T, Naghavi, M, Neal, B, Nelson, PK, Nolla, JM, Norman, R, Olives, C, Omer, SB, Orchard, J, Osborne, R, Ostro, B, Page, A, Pandey, KD, Parry, CDH, Passmore, E, Patra, J, Pearce, N, Pelizzari, PM, Petzold, M, Phillips, MR, Pope, D, Pope III, CA, Powles, J, Rao, M, Razavi, H, Rehfuess, EA, Rehm, JT, Ritz, B, Rivara, FP, Roberts, T, Robinson, C, Rodriguez-Portales, JA, Romieu, I, Room, R, Rosenfeld, LC, Roy, A, Rushton, L, Salomon, JA, Sampson, U, Sanchez-Riera, L, Sanman, E, Sapkota, A, Seedat, S, Shi, P, Shield, K, Shivakoti, R, Singh, GM, Sleet, DA, Smith, E, Smith, KR, Stapelberg, NJC, Steenland, K, Stöckl, H, Stovner, LJ, Straif, K, Straney, L, Thurston, GD, Tran, JH, Van Dingenen, R, van Donkelaar, A, Veerman, JL, Vijayakumar, L, Weintraub, R, Weissman, MM, White, RA, Whiteford, H, Wiersma, ST, Wilkinson, JD, Williams, HC, Williams, W, Wilson, N, Woolf, AD, Yip, P, Zielinski, JM, Lopez, AD, Murray, CJL, Ezzati, M (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 22242260.
Llibre Rodríguez, J, Valhuerdi, A, Sanchez, II, Reyna, C, Guerra, MA (2008). The prevalence, correlates and impact of dementia in Cuba: a 10/66 Group population-based survey. Neuroepidemiology 31, 243251.
Lozano, R, Naghavi, M, Foreman, K, Lim, S, Shibuya, K, Aboyans, V, Abraham, J, Adair, T, Aggarwal, R, Ahn, SY (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010: Supplementary appendix. Lancet 380.
Malone, D, Marriott, S, Newton-Howes, G, Simmonds, S, Tyrer, P (2007). Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality. Cochrane Database of Systematic Reviews 3, Art. No.: CD000270. doi: 10.1002/14651858.CD000270.pub2.
Mathers, BM, Degenhardt, L, Ali, H, Wiessing, L, Hickman, M, Mattick, RP, Myers, B, Ambekar, A, Strathdee, SA (2010). HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 375, 10141028.
Mattick, RP, Kimber, J, Breen, C, Davoli, M (2008). Buprenorphine Maintenance Versus Placebo or Methadone Maintenance for Opioid Dependence. Cochrane Database of Systematic Reviews [Online], 2008. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002207.pub4/full
Mattick, RP, Breen, C, Kimber, J, Davoli, M (2009). Methadone Maintenance Therapy Versus no Opioid Replacement Therapy for Opioid Dependence. Cochrane Database of Systematic Reviews [Online], 2009. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002209.pub2/full
Mitchell, SL, Teno, JM, Kiely, DK, Shaffer, ML, Jones, RN, Prigerson, HG, Volicer, L, Givens, JL, Hamel, MB (2009). The clinical course of advanced dementia. New England Journal of Medicine 361, 15291538.
Mouridsen, SE, Bronnum-Hansen, H, Rich, B, Isager, T (2008). Mortality and causes of death in autism spectrum disorders: an update. Autism 12, 403414.
Mu, J, Liu, L, Zhang, Q, Si, Y, Hu, J, Fang, J, Gao, Y, He, J, Li, S, Wang, W, Wu, J, Sander, JW, Zhou, D (2011). Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology 77, 132137.
Murray, CJL, Vos, T, Lozano, R, Naghavi, M, Flaxman, AD, Michaud, C, Ezzati, M, Shibuya, K, Salomon, JA, Abdalla, S, Aboyans, V, Abraham, J, Ackerman, I, Aggarwal, R, Ahn, SY, Ali, MK, Alvarado, M, Anderson, HR, Anderson, LM, Andrews, KG, Atkinson, C, Baddour, LM, Bahalim, AN, Barker-Collo, S, Barrero, LH, Bartels, DH, Basáñez, M-G, Baxter, A, Bell, ML, Benjamin, EJ, Bennett, D, Bernabé, E, Bhalla, K, Bhandari, B, Bikbov, B, Abdulhak, AB, Birbeck, G, Black, JA, Blencowe, H, Blore, JD, Blyth, F, Bolliger, I, Bonaventure, A, Boufous, S, Bourne, R, Boussinesq, M, Braithwaite, T, Brayne, C, Bridgett, L, Brooker, S, Brooks, P, Brugha, TS, Bryan-Hancock, C, Bucello, C, Buchbinder, R, Buckle, G, Budke, CM, Burch, M, Burney, P, Burstein, R, Calabria, B, Campbell, B, Canter, CE, Carabin, H, Carapetis, J, Carmona, L, Cella, C, Charlson, F, Chen, H, Cheng, AT-A, Chou, D, Chugh, SS, Coffeng, LE, Colan, SD, Colquhoun, S, Colson, KE, Condon, J, Connor, MD, Cooper, LT, Corriere, M, Cortinovis, M, de Vaccaro, KC, Couser, W, Cowie, BC, Criqui, MH, Cross, M, Dabhadkar, KC, Dahiya, M, Dahodwala, N, Damsere-Derry, J, Danaei, G, Davis, A, Leo, DD, Degenhardt, L, Dellavalle, R, Delossantos, A, Denenberg, J, Derrett, S, Des Jarlais, DC, Dharmaratne, SD, Dherani, M, Diaz-Torne, C, Dolk, H, Dorsey, ER, Driscoll, T, Duber, H, Ebel, B, Edmond, K, Elbaz, A, Ali, SE, Erskine, H, Erwin, PJ, Espindola, P, Ewoigbokhan, SE, Farzadfar, F, Feigin, V, Felson, DT, Ferrari, A, Ferri, CP, Fèvre, EM, Finucane, MM, Flaxman, S, Flood, L, Foreman, K, Forouzanfar, MH, Fowkes, FGR, Fransen, M, Freeman, MK, Gabbe, BJ, Gabriel, SE, Gakidou, E, Ganatra, HA, Garcia, B, Gaspari, F, Gillum, RF, Gmel, G, Gonzalez-Medina, D, Gosselin, R, Grainger, R, Grant, B, Groeger, J, Guillemin, F, Gunnell, D, Gupta, R, Haagsma, J, Hagan, H, Halasa, YA, Hall, W, Haring, D, Haro, JM, Harrison, JE, Havmoeller, R, Hay, RJ, Higashi, H, Hill, C, Hoen, B, Hoff man, H, Hotez, PJ, Hoy, D, Huang, JJ, Ibeanusi, SE, Jacobsen, KH, James, SL, Jarvis, D, Jasrasaria, R, Jayaraman, S, Johns, N, Jonas, JB, Karthikeyan, G, Kassebaum, N, Kawakami, N, Keren, A, Khoo, J-P, King, CH, Knowlton, LM, Kobusingye, O, Koranteng, A, Krishnamurthi, R, Laden, F, Lalloo, R, Laslett, LL, Lathlean, T, Leasher, JL, Lee, YY, Leigh, J, Levinson, D, Lim, SS, Limb, E, Lin, JK, Lipnick, M, Lipshultz, SE, Liu, W, Loane, M, Ohno, SL, Lyons, R, Mabweijano, J, MacIntyre, MF, Malekzadeh, R, Mallinger, L, Manivannan, S, Marcenes, W, March, L, Margolis, DJ, Marks, GB, Marks, R, Matsumori, A, Matzopoulos, R, Mayosi, BM, McAnulty, JH, McDermott, MM, McGill, N, McGrath, J, Medina-Mora, ME, Meltzer, M, Mensah, GA, Merriman, TR, Meyer, A-C, Miglioli, V, Miller, M, Miller, TR, Mitchell, PB, Mock, C, Mocumbi, AO, Moffitt, TE, Mokdad, AA, Monasta, L, Montico, M, Moradi-Lakeh, M, Moran, A, Morawska, L, Mori, R, Murdoch, ME, Mwaniki, MK, Naidoo, K, Nair, MN, Naldi, L, Venkat Narayan, KM, Nelson, PK, Nelson, RG, Nevitt, MC, Newton, CR, Nolte, S, Norman, P, Norman, R, O'Donnell, M, O'Hanlon, S, Olives, C, Omer, SB, Ortblad, K, Osborne, R, Ozgediz, D, Page, A, Pahari, B, Pandian, JD, Rivero, AP, Patten, SB, Pearce, N, Perez Padilla, R, Perez-Ruiz, F, Perico, N, Pesudovs, K, Phillips, D, Phillips, MR, Pierce, K, Pion, S, Polanczyk, GV, Polinder, S, Pope III, CA, Popova, S, Porrini, E, Pourmalek, F, Prince, M, Pullan, RL, Ramaiah, KD, Ranganathan, D, Razavi, H, Regan, M, Rehm, JT, Rein, DB, Remuzzi, G, Richards, K (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 21972223.
Neligan, A, Bell, GS, Shorvon, SD, Sander, JW (2010). Temporal trends in the mortality of people with epilepsy: a review. Epilepsia 51, 22412246.
Nelson, PK, Mathers, BM, Cowie, B, Hagan, H, Des Jarlais, D, Horyniak, D, Degenhardt, L (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 378, 571583.
Newcomer, JW (2005). Second-generation (atypical) antipsychotics and metabolic effects. CNS Drugs 19, 193.
Newton, CR, Garcia, HH (2012). Epilepsy in poor regions of the world. Lancet 380, 1193–201.
Ngugi, AK, Bottomley, C, Fegan, G, Chengo, E, Odhiambo, R, Bauni, E, Neville, B, Kleinschmidt, I, Sander, JW, Newton, CR (2014). Premature mortality in active convulsive epilepsy in rural Kenya: causes and associated factors. Neurology 82, 582589.
Park, JE, Lee, JY, Suh, GH, Kim, BS, Cho, MJ (2014). Mortality rates and predictors in community-dwelling elderly individuals with cognitive impairment: an eight-year follow-up after initial assessment. International Psychogeriatrics 26, 1295–304.
Preux, P-M, Druet-Cabanac, M (2005). Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurology 4, 2131.
Prince, M, Patel, V, Saxena, S, Maj, M, Maselko, J, Phillips, MR, Rahman, A (2007). No health without mental health. Lancet 370, 859877.
Rao Um, A, Daley, SE, Hammen, C (2000). Relationship between depression and substance use disorders in adolescent women during the transition to adulthood. Journal of the American Academy of Child and Adolescent Psychiatry 39, 215222.
Rehm, J, Baliunas, D, Borges, GLG, Graham, K, Irving, H, Kehoe, T, Parry, CD, Patra, J, Popova, S, Poznyak, V, Roerecke, M, Room, R, Samokhvalov, AV, Taylor, B (2010 a). The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 105, 817843.
Rehm, J, Taylor, B, Mohapatra, S, Irving, H, Baliunas, D, Patra, J, Roerecke, M (2010 b). Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug and Alcohol Review 29, 437445.
Rohde, P, Lewinsohn, PM, Kahler, CW, Seeley, JR, Brown, RA (2001). Natural course of alcohol use disorders from adolescence to young adulthood. Journal of the American Academy of Child and Adolescent Psychiatry 40, 8390.
Roshanaei-Moghaddam, B, Katon, W (2009). Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatric Services 60, 147156.
Rowe, R, Maughan, B, Goodman, R (2004). Childhood psychiatric disorder and unintentional injury: findings from a national cohort study. Journal of Pediatric Psychology 29, 119130.
Rummel-Kluge, C, Komossa, K, Schwarz, S, Hunger, H, Schmid, F, Lobos, CA, Kissling, W, Davis, JM, Leucht, S (2010). Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophrenia Research 123, 225233.
Salomon, JA, Wang, H, Freeman, MK, Vos, T, Flaxman, AD, Lopez, AD, Murray, CJL (2012). Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 380, 21442162.
Scott, D, Happell, B (2011). The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness. Issues in Mental Health Nursing 32, 589597.
Scott, KM, Wu, B, Saunders, K, Benjet, C, He, Y, Lepine, J-P, Tachimori, H, Van Korff, M (2013). Early-onset mental disorders and their links to chronic physical conditions in adulthood. In The Burdens of Mental Disorders (ed. Alonso, J, Chatterji, S and He, Y). Global Perspectives from the WHO World Mental Health Surveys. Cambridge University Press: New York, 8795.
Shatenstein, B, Kergoat, M-J, Reid, I (2007). Poor nutrient intakes during 1-year follow-Uu with community dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls. Journal of the American Dietetic Association 107, 20912099.
Shavelle, RM, Strauss, DJ, Pickett, J (2001). Causes of death in autism. Journal of Autism and Developmental Disorders 31, 569576.
Sillanpaa, M, Shinnar, S (2010). Long-term mortality in childhood-onset epilepsy. New England Journal of Medicine 363, 25222529.
Smith, M, Hopkins, D, Peveler, RC, Holt, RIG, Woodward, M, Ismail, K (2008). First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry 192, 406411.
Sporer, KA (2003). Strategies for preventing heroin overdose. British Medical Journal, 326, 442444.
Sporer, KA, Kral, AH (2007). Prescription naloxone: a novel approach to heroin overdose prevention. Annals of Emergency Medicine 49, 172177.
Swan, T (2011). Hepatitis C Treatment Pipeline Report. Treatment Action Group: New York, NY.
Thornicroft, G (2013). Premature death among people with mental illness: at best a failure to act on evidence; at worst a form of lethal discrimination. British Medical Journal 346:f3423.
Trinka, E, Bauer, G, Oberaigner, W, Ndayisaba, JP, Seppi, K, Granbichler, CA (2013). Cause-specific mortality among patients with epilepsy: results from a 30-year cohort study. Epilepsia 54, 495501.
Turner Km, E, Hutchinson, S, Vickerman, P, Hope, V, Craine, N, Palmateer, N, May, M, Taylor, A, De Angelis, D, Cameron, S, Parry, J, Lyons, M, Goldberg, D, Allen, E, Hickman, M (2011). The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction 106, 19781988.
Tyrer, F, Mcgrother, C (2009). Cause-specific mortality and death certificate reporting in adults with moderate to profound intellectual disability. Journal of Intellectual Disability Research 53, 898904.
Von Stumm, S, Deary, IJ, Kivimäki, M, Jokela, M, Clark, H, Batty, GD (2011). Childhood behavior problems and health at midlife: 35-year follow-up of a Scottish birth cohort. Journal of Child Psychology and Psychiatry 52, 9921001.
Vos, T, Flaxman, AD, Naghavi, M, Lozano, R, Michaud, C, Ezzati, M, Shibuya, K, Salomon, JA, Abdalla, S, Aboyans, V, Abraham, J, Ackerman, I, Aggarwal, R, Ahn, SY, Ali, MK, Alvarado, M, Anderson, HR, Anderson, LM, Andrews, KG, Atkinson, C, Baddour, LM, Bahalim, AN, Barker-Collo, S, Barrero, LH, Bartels, DH, Basáñez, M-G, Baxter, A, Bell, ML, Benjamin, EJ, Bennett, D, Bernabé, E, Bhalla, K, Bhandari, B, Bikbov, B, Bin Abdulhak, A, Birbeck, G, Black, JA, Blencowe, H, Blore, JD, Blyth, F, Bolliger, I, Bonaventure, A, Boufous, S, Bourne, R, Boussinesq, M, Braithwaite, T, Brayne, C, Bridgett, L, Brooker, S, Brooks, P, Brugha, TS, Bryan-Hancock, C, Bucello, C, Buchbinder, R, Buckle, G, Budke, CM, Burch, M, Burney, P, Burstein, R, Calabria, B, Campbell, B, Canter, CE, Carabin, H, Carapetis, J, Carmona, L, Cella, C, Charlson, F, Chen, H, Cheng, AT-A, Chou, D, Chugh, SS, Coffeng, LE, Colan, SD, Colquhoun, S, Colson, KE, Condon, J, Connor, MD, Cooper, LT, Corriere, M, Cortinovis, M, de Vaccaro, KC, Couser, W, Cowie, BC, Criqui, MH, Cross, M, Dabhadkar, KC, Dahiya, M, Dahodwala, N, Damsere-Derry, J, Danaei, G, Davis, A, De Leo, D, Degenhardt, L, Dellavalle, R, Delossantos, A, Denenberg, J, Derrett, S, Des Jarlais, DC, Dharmaratne, SD, Dherani, M, Diaz-Torne, C, Dolk, H, Dorsey, ER, Driscoll, T, Duber, H, Ebel, B, Edmond, K, Elbaz, A, Ali, SE, Erskine, H, Erwin, PJ, Espindola, P, Ewoigbokhan, SE, Farzadfar, F, Feigin, V, Felson, DT, Ferrari, A, Ferri, CP, Fèvre, EM, Finucane, MM, Flaxman, S, Flood, L, Foreman, K, Forouzanfar, MH, Fowkes, FGR, Franklin, R, Fransen, M, Freeman, MK, Gabbe, BJ, Gabriel, SE, Gakidou, E, Ganatra, HA, Garcia, B, Gaspari, F, Gillum, RF, Gmel, G, Gosselin, R, Grainger, R, Groeger, J, Guillemin, F, Gunnell, D, Gupta, R, Haagsma, J, Hagan, H, Halasa, YA, Hall, W, Haring, D, Haro, JM, Harrison, JE, Havmoeller, R, Hay, RJ, Higashi, H, Hill, C, Hoen, B, Hoff man, H, Hotez, PJ, Hoy, D, Huang, JJ, Ibeanusi, SE, Jacobsen, KH, James, SL, Jarvis, D, Jasrasaria, R, Jayaraman, S, Johns, N, Jonas, JB, Karthikeyan, G, Kassebaum, N, Kawakami, N, Keren, A, Khoo, J-P, King, CH, Knowlton, LM, Kobusingye, O, Koranteng, A, Krishnamurthi, R, Lalloo, R, Laslett, LL, Lathlean, T, Leasher, JL, Lee, YY, Leigh, J, Lim, SS, Limb, E, Lin, JK, Lipnick, M, Lipshultz, SE, Liu, W, Loane, M, Ohno, SL, Lyons, R, Ma, J, Mabweijano, J, MacIntyre, MF, Malekzadeh, R, Mallinger, L, Manivannan, S, Marcenes, W, March, L, Margolis, DJ, Marks, GB, Marks, R, Matsumori, A, Matzopoulos, R, Mayosi, BM, McAnulty, JH, McDermott, MM, McGill, N, McGrath, J, Medina-Mora, ME, Meltzer, M, Mensah, GA, Merriman, TR, Meyer, A-C, Miglioli, V, Miller, M, Miller, TR, Mitchell, PB, Mocumbi, AO, Moffitt, TE, Mokdad, AA, Monasta, L, Montico, M, Moradi-Lakeh, M, Moran, A, Morawska, L, Mori, R, Murdoch, ME, Mwaniki, MK, Naidoo, K, Nair, MN, Naldi, L, Venkat Narayan, KM, Nelson, PK, Nelson, RG, Nevitt, MC, Newton, CR, Nolte, S, Norman, P, Norman, R, O'Donnell, M, O'Hanlon, S, Olives, C, Omer, SB, Ortblad, K, Osborne, R, Ozgediz, D, Page, A, Pahari, B, Pandian, JD, Rivero, AP, Patten, SB, Pearce, N, Perez Padilla, R, Perez-Ruiz, F, Perico, N, Pesudovs, K, Phillips, D, Phillips, MR, Pierce, K, Pion, S, Polanczyk, GV, Polinder, S, Pope III, CA, Popova, S, Porrini, E, Pourmalek, F, Prince, M, Pullan, RL, Ramaiah, KD, Ranganathan, D, Razavi, H, Regan, M, Rehm, JT, Rein, DB, Remuzzi, G, Richardson, K, Rivara, FP, Roberts, T, Robinson, C, De Leòn, FR (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990?2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 21632196.
Wahlbeck, K, Westman, J, Nordentoft, M, Gissler, M, Laursen, TM (2011). Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. British Journal of Psychiatry 199, 453458.
Weinmann, S, Read, J, Aderhold, V (2009). Influence of antipsychotics on mortality in schizophrenia: systematic review. Schizophrenia Research 113, 111.
Westman, J, Hallgren, J, Wahlbeck, K, Erlinge, D, Alfredsson, L, Osby, U (2013). Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden . BMJ Open 3, e002373. doi:10.1136/bmjopen-2012-002373.
Whiteford, HA, Degenhardt, L, Rehm, J, Baxter, AJ, Ferrari, AJ, Erskine, HE, Charlson, FJ, Norman, RE, Flaxman, AD, Johns, N, Burstein, R, Murray, CJL, Vos, T (2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382, 15751586.
World Health Organization (1993). The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research, World Health Organization.
World Health Organization (2005). WHO Model List of Essential Medicines.

Keywords

Type Description Title
WORD
Supplementary materials

Charlson Supplementary Material
Supplementary Material

 Word (201 KB)
201 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed